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Abstract: The need for alternatives to antibiotics in the fight against infectious diseases has inspired
scientists to focus on antivirulence factors instead of the microorganisms themselves. In this respect,
prior work indicates that tiny, enclosed bilayer lipid membranes (liposomes) have the potential to
compete with cellular targets for toxin binding, hence preventing their biological attack and aiding
with their clearance. The effectiveness of liposomes as decoy targets depends on their availability
in the host and how rapidly they are cleared from the circulation. Although liposome PEGylation
may improve their circulation time, little is known about how such a modification influences their
interactions with antivirulence factors. To fill this gap in knowledge, we investigated regular and
long-circulating liposomes for their ability to prevent in vitro red blood cell hemolysis induced
by two potent lytic toxins, lysenin and streptolysin O. Our explorations indicate that both regular
and long-circulating liposomes are capable of similarly preventing lysis induced by streptolysin O.
In contrast, PEGylation reduced the effectiveness against lysenin-induced hemolysis and altered
binding dynamics. These results suggest that toxin removal by long-circulating liposomes is feasible,
yet dependent on the particular virulence factor under scrutiny.
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1. Introduction
Secreted pore-forming toxins (PFTs) are a distinct class of molecules that disrupt
the barrier function through introducing large, unregulated pores in the host cell membranes [1–6]. Bacterial-secreted PFTs are virulence factors that actively participate in the
infectious process [7–11]: their biological activity may lead to cell death, creating a microenvironment that promotes pathogen proliferation, weakening the immune response
and spreading to other hosts [12–15]. Interrupting this cascade of events by preventing
permeabilization is anticipated to diminish their contribution to infectivity and burden on
the immune system, hence promoting clearance and health restoration.
Similar to many other toxins, PFTs must first interact with the components of cell
membranes to exert their biological activity. This interaction is often a multi-step process
consisting of binding, oligomerization and the creation of conducting pathways; therefore,
interrupting one of these steps may constitute an effective strategy for mitigating the
infectivity of cytolysin-releasing pathogens. Molecular inhibitors acting as decoys by
mimicking the target and competing for binding have been investigated as effective tools
for preventing toxin–membrane interactions [16–21]. In the same line, the inhibition of
oligomerization or the blockage of the conducting pathway of PFTs constitutes other means
for preventing PFT-induced permeabilization [22–24].
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A more general approach derived from the same inhibitory principle relies on using
membrane-based decoys as target binding competitors [25–30]. Instead of using individual molecules, this strategy introduces larger membrane-based structures as competitors
designed to present a high affinity for target binding. In this endeavor, one promising
approach is based on employing liposomes as decoys [25,28,30]. While liposomes do not
possess direct antibacterial capabilities, they compete with host cells to bind the toxins,
sequester them and contribute to their clearance. Their use for this purpose has several
advantages over alternative molecular-based approaches. Liposomes have been investigated for many decades as vehicles for drug-delivery; liposomes loaded with antineoplastic
drugs are used for cancer therapy and their pharmacology and side-effects are well documented [31–38]. Their composition may be adjusted to effectively compete with the host
cells by including specific molecular targets that present a high affinity for a specific toxin
or a class of toxins. For example, experiments conducted with liposomes composed of
cholesterol (Chol) and sphingomyelin (SM) proved effective against cholesterol-dependent
cytolysins (streptolysin O (SLO), pneumolysin, tetanolysin, α-hemolysin) and phospholipase C [28]. Similar liposomes proved effective for attenuating dermonecrosis induced by
Methicillin resistant Staphylococcus aureus by sequestering both the PFT α-hemolysin and
the α-type phenol-soluble modulin cytolitic factors [30]. A somewhat similar approach
utilized a nanosponge consisting of substrate-supported red blood cell (RBC) bilayer
membranes to divert α-hemolysin away from cellular targets [29]. Nanoscale biomimetic
particles based on RBC membranes have been proposed for the clearance of pathological
antibodies [26], pathogenic bacteria [27] and toxins [27,29]. This body of evidence strongly
supports the use of liposomes as effective targets for toxins.
One of the potential issues for the in vivo application of liposomes as toxin removal
tools is the reticulo-endothelial system (RES)/mononuclear phagocyte system (MPS) clearance from circulation [39–42]. Prior in vivo experiments showed that long-circulating,
SM-rich liposomes had a half-maximal decline at 4 h owing to elimination by splenic
macrophages, which may lead to the requirement of multiple treatments with liposomes at
short time intervals [28]. This may also limit the applicability of liposomes to effectively
remove only toxins for which SM is a preferred target. Therefore, a better clinical outcome
for a liposome-based treatment may be achieved by improving the circulation time of the
liposomes irrespective of their composition. In this respect, PEGylated liposomes (also
known as Stealth or sterically stabilized) may present a longer circulation time in the
blood stream [40,43]. Although the biodistribution of SM-rich liposomes was considered
to be similar to PEGylated liposomes in rabbits [31], size can make a great difference.
Only large PEGylated liposomes (i.e., >300 nm diameter) presented a median circulation
time of ~4 h, similar to the SM-rich liposomes, while the median half-life of smaller liposomes (i.e., <275 nm diameter) exceeded 20 h [31]. Consequently, one may anticipate
that a longer bioavailability may improve the efficacy of the liposome-based treatment of
infectious diseases.
As PEG addition is intended to minimize undesired interactions, we asked whether
or not such liposomes are efficient targets for toxins, hence actively contributing to their
clearance. To answer this question, we investigated the ability of PEGylated liposomes
(herein, long-circulating liposomes) to prevent RBC lysis elicited by two potent poreforming toxins, SLO [44,45] and lysenin [46–48]. Our results suggest that long-circulating
liposomes are also effective inhibitors of lysis although their effectiveness for particular
toxins may be significantly reduced. In addition, the analysis of the inhibition plots revealed
that the toxin binding to target membranes is a cooperative process also influenced by the
toxin’s identity and lipid composition of the liposomes.
2. Materials and Methods
2.1. Materials
Asolectin (Aso, Sigma-Aldrich, St. Louis, MO, USA), Chol (Sigma-Aldrich), brain SM
(Avanti Lipids, Alabaster, AL, USA) and distearoyl-phosphatidylethanolamine-PEG2000
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(DSPE-PEG, Avanti Lipids) were purchased either as powders or chloroform solutions
and stored at −20 ◦ C. The powders were solubilized in chloroform prior to the liposome
preparation. Whole sheep blood in Alsever’s solution (Colorado Serum Company, Denver,
CO, USA) was stored at 4 ◦ C and used within several days after receiving it. SLO and
lysenin (both from Sigma-Aldrich) were prepared as described below and stored in the
freezer until use. All of the buffered solutions were prepared in deionized water (DI H2 O)
using analytical grade chemicals purchased from various vendors.
2.2. Methods
2.2.1. Liposome Preparation and Characterization
Regular and long-circulating liposomes for capturing lysenin or SLO and preventing RBC hemolysis were prepared using sonication [28] or extrusion [49,50] methods.
Regular liposomes capable of binding lysenin were prepared from Aso, Chol and SM.
Long-circulating liposomes were produced from the same composition with added DSPEPEG. To capture SLO, regular liposomes were produced by sonication and extrusion from
mixtures of Aso and Chol; long-circulating liposomes comprised an addition of DSPE-PEG.
The control liposomes were also prepared without the addition of SM or Chol. The powder
lipids were dissolved in chloroform, mixed at specific ratios and dried in a glass vial
under vacuum for 24 h. The formed lipid cakes were hydrated for a few hours at 60 ◦ C in
phosphate buffer saline (PBS) at pH = 7.4. Following hydration, the mixtures underwent
four freezing-thawing cycles, after which the liposomes were prepared by either sonication
or extrusion. The sonicated liposomes were prepared with a Misonix S-4000 Sonicator
(Misonix, Farmingdale, NY, USA) equipped with a micro-tip immersed in the vials kept on
ice during the procedure to avoid overheating the sample. The sonication was performed
for ~15 min at 25% amplitude and a power transfer of 6–7 W. Liposome extrusion was performed for a total of 81 passes with an Avanti Lipids extruder (200 nm polycarbonate filters,
Avanti Lipids) at 75 ◦ C. After preparation, the liposomes were characterized for an average
hydrodynamic diameter and polydispersity index (PDI) by dynamic light scattering (DLS,
Malvern ZetaSizer, Malvern Panalytical Inc., Westborough, MA, USA) at room temperature
and stored in a refrigerator. For each liposome sample, we analyzed three sets and each set
consisted of 13 consecutive runs. Each set provided the corresponding average diameter
and PDI, from which we calculated the mean values and standard deviations (n = 3) as
reported in the main text.
Before the experimentation, the liposome solutions were kept at room temperature for
two hours for thermal equilibration. The exact compositions and physical characterization
data of the liposomes are detailed in the Results and Discussion section.
2.2.2. Red Blood Cell Preparation
The whole sheep blood in Alsever’s solution was centrifuged at 3500 RPM for five
minutes and rinsed with PBS. After three centrifugation-rinse cycles, the RBCs were resuspended in PBS to a density of ~9 × 109 cells/mL (as determined with a bench cytometer).
For the hemolysis experiments, the washed RBCs were diluted in PBS as detailed in the
Results and Discussion section.
2.2.3. Toxin Preparation
A stock solution of SLO was prepared by dissolving the lyophilized compound
(~100 ku) in 0.5 mL freezing buffer (100 mM NaCl, 1 mM EDTA, 50 mM Hepes, 1 mM
Tris-(2-Carboxyethyl)phosphine-HCl, 0.02% NaN3 and 10% glycerol (pH = 7.2). A stock
solution of lysenin was prepared by dissolving 50 µg of the lyophilized product in 0.5 mL
DI H2 O. Further dilutions of the stock solutions were made in PBS.
2.2.4. Determination of Hemolysis Rate
The extent of hemolysis for the controls and exposed samples was indirectly determined by both a visual inspection and by measuring the optical absorption presented
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by the released hemoglobin in the supernatant [47,51,52] with a Varian Carry 5000 spectrophotometer (Agilent Technologies Inc., Santa Clara, CA, USA). The inhibition plots were
represented as relative hemolysis (determined from absorption at 576 nm) as a function of
the total amounts of added lipids/sample (including the Chol). The relative hemolysis was
calculated by using the formula:
Hemolysis% =

As − Ac
× 100
Amax

(1)

where As was the absorption presented by the sample, Ac was the absorption of the
control (an otherwise identical sample but containing no added toxin) and Amax was
the absorption recorded for the sample containing the toxin but no liposomes added as
inhibitors (this absorbance value was set as 100% hemolysis). The absorption was measured
at room temperature with the samples placed in 1 cm path length semi-micro cuvettes. All
absorption measurements were performed in triplicate; the absorption spectra were shown
as single typical runs and the inhibition curves reported mean values. The preliminary
experimentation established that a 20 min exposure of RBC samples to various amounts of
toxins at room temperature was sufficient to achieve a steady state of hemolysis. For the
data analysis, we adapted the four parameter logistic (Hill slope) equation [53] to describe
the relationship between hemolysis and liposome amounts:
1

Hemolysis% =
1+



x
EA50

 p × 100

(2)

where x was the amount of lipids (in the liposomes) added to each sample including Chol,
EA50 was the effective amount of lipids that set the inhibition halfway (i.e., 50%) and p was
the Hill coefficient.
3. Results and Discussions
3.1. Liposome Characterization
The detailed compositions and physical characterization of liposomes prepared by
sonication or extrusion and utilized in this work are presented in Table 1; liposome characterization by DLS provided the average diameter and polydispersity index (PDI).
Table 1. Liposome characterization.

Code *

Composition ** (mg/mL)
Aso:Chol:SM:DSPE-PEG

Average Diameter, nm
(Mean ± SD, n = 3)

PDI
(Mean ± SD,
n = 3)

Preparation
Method

R1
S1
R2
S2
R3
S3
R4
S4
RC1
RC2

5:4:6:0
5:4:6:2
5:4:6:0
5:4:6:2
10:6:0:0
10:6:0:3
10:6:0:0
10:6:0:3
10:6:0:0
10:0:0:0

102 ± 9
95 ± 8
193 ± 3
214 ± 4
138 ± 6
144 ± 6
233 ± 11
238 ± 12
236 ± 11
268 ± 12

0.31 ± 0.06
0.28 ± 0.05
0.11 ± 0.003
0.09 ± 0.002
0.32 ± 0.07
0.22 ± 0.07
0.12 ± 0.002
0.09 ± 0.002
0.11 ± 0.002
0.33 ± 0.08

Sonication
Sonication
Extrusion
Extrusion
Sonication
Sonication
Extrusion
Extrusion
Extrusion
Sonication

* R indicates regular (no PEG lipids) and S indicates long-circulating (PEG lipids added) liposomes. ** asolectin (Aso), cholesterol (Chol),
sphingomyelin (SM), distearoyl-phosphatidylethanolamine-PEG2000 (DSPE-PEG).

The lipid compositions were adjusted to match the target lipid component in the
membrane; for example, SLO requires cholesterol [5,6,45] while binding and pore formation
by lysenin is conditioned by the presence of SM in the target membrane [46,48]. In addition,
to compare long-circulating and regular liposomes as inhibitors of the lytic activity of the

* R indicates regular (no PEG lipids) and S indicates long-circulating (PEG lipids added) liposomes.
** asolectin (Aso), cholesterol (Chol), sphingomyelin (SM), distearoyl-phosphatidylethanolamine-PEG2000 (DSPE-PEG).
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have a strong lytic activity stemming from the large conductance pores introduced into the
target membranes. However, their mechanisms of primary interaction with membranes are
different; their lytic activity depends on the target membrane and solution compositions as
well as other environmental factors. The hemolytic activity of the two toxins was not well
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3.4. Liposomes Inhibit Lysenin-Induced RBC Hemolysis in a Concentration-Dependent Manner
We then focused our investigations on exploring the ability of regular and longcirculating liposomes produced by either sonication or extrusion to prevent hemolysis
of RBCs exposed to lysenin. Throughout these experiments we used 40 µL of stock RBC
solution for a total volume of 400 µL, which included all of the reaction components. For
a preliminary visual comparison, we produced samples exposed to ~12 ng lysenin and
increasing amounts of sonicated liposomes (R1) together with control samples consisting
of RBCs in PBS (no lysenin), RBCs fully lysed by exposure to pure water and RBCs in PBS
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420 and 1680 µg) added to lysenin-exposed samples (4–8) gradually inhibited hemolysis.

The relative hemolysis plots constructed for regular liposomes produced by either
sonication (R1) or extrusion (R2) provided additional information on the effectiveness of
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hemolysis
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produced
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as inhibitors
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hemolysis.
For both
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The plots
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(R2)determined
provided as
additional
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on theincreased.
effectiveness
of
(Figure
4)
resembled
typical
inhibition
experiments
and
they
were
fitted
with
the
logistic
liposomes as inhibitors of lysenin-induced hemolysis. For both cases, a steep decrease of
function (Hill) to compare the effectiveness and assess potential cooperative effects. The
hemolysis was determined
as the amount of added liposome increased. The plots
50% effective amount (EA50 ) determined for the sonicated liposomes (R1) was 38 ± 3 µg;
(Figure 4) resembled
typical
inhibition
and
were
with the(p)lofor extruded
liposomes
(R2) experiments
this amount was
32 they
± 5 µg.
Thefitted
Hill coefficient
was
gistic function (Hill)
to
compare
the
effectiveness
and
assess
potential
cooperative
also similar for the two, i.e., 1.2 ± 0.2 for sonicated liposomes and 1.3 ± 0.3 foreffects.
extruded
of a slight positive
cooperativity.
The 50% effectiveliposomes,
amount indicative
(EA50) determined
for the
sonicated liposomes (R1) was 38 ± 3
The
ability
of
long-circulating
liposomes
by either
sonication (S1)
extruµg; for extruded liposomes (R2) this amount was 32 ±produced
5 µg. The
Hill coefficient
(p)orwas
sion (S2) to prevent lysenin-induced hemolysis was assessed in a similar experimental
also similar for the
two, i.e., 1.2 ± 0.2 for sonicated liposomes and 1.3 ± 0.3 for extruded
setup. Both products effectively inhibited hemolysis to negligible values upon the addition
liposomes, indicative
of a slight
positive
of amounts
exceeding
200 µgcooperativity.
of lipids (Figure 4). A data analysis unveiled more intricate
inhibition plots presenting a pronounced sigmoidal shape. In contrast to regular liposomes,
which indicated at most a weak positive cooperativity, the Hill coefficient determined for
long-circulating liposomes was p = 3.1 ± 0.2 for sonicated liposomes and p = 3.0 ± 0.1 for
the extrusion methods. This suggests cooperativity stronger than what we determined
for regular liposomes interacting with lysenin. The corresponding EA50 s were also larger
(298 ± 10 µg for sonicated liposomes and 328 ± 11 µg for extruded liposomes), which
were up to 10 times higher than the doses determined for regular liposomes. A reasonable
explanation for this reduced effectiveness is that PEGylation modulates the interactions
between lysenin and membranes, ultimately influencing binding, oligomerization or pore
formation. Such a modulation was expected because liposome PEGylation is intended to
prolong the circulation by preventing undesired interactions and the eventual recognition
by the immune system of the host but it is not clear why this effect was not observed for
SLO. We suspect that the differences between the pore formation mechanisms of the two
toxins may play a major role in this modulation.
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specific interaction between the toxin and membranes leading to pore formation. All of
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3.5. SLO-Induced Lysis Is Prevented by Liposomes in a Concentration-Dependent Manner
Our next investigations assessed the inhibitory effects of liposomes on SLO-induced
hemolysis. The hemolysis rate of RBCs exposed to SLO in the presence of varying concentrations of regular liposomes produced by either sonication (R3) or extrusion (R4) is
shown in Figure 6. Irrespective of the production method, the RBC lysis was prevented in
an anticipated concentration-dependent manner. The reduction in hemolysis was observed for small amounts of added liposomes and a very steep decrease was observed as
the amount of added liposomes increased. Hemolysis was inhibited for lipid amounts
exceeding 60 µg, indicative of a near complete prevention of the activity of the toxin. The
Hill slope equation provided a similar EA50 for both sonicated and extruded liposomes,
i.e., 5.8 ± 0.6 µg and 7.0 ± 0.3 µg, respectively. A similar Hill coefficient was also obtained
from the fit for both preparation methods (p = 1.8 ± 0.1 for sonicated liposomes and p = 1.7
± 0.1 for extruded liposomes) indicating a positive cooperativity, which probably originated in the specific interaction between the toxin and membranes leading to pore formation. All of these results pointed out that sonication and extrusion yielded liposomes
with a similar inhibition efficacy of the SLO’s lytic activity.
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theequation
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The addition of long-circulating liposomes produced by either sonication (S3) or
extrusion (S4) also influenced SLO-induced hemolysis and diminished it in a concentration-dependent manner (Figure 6) similar to the regular liposomes. Hemolysis decayed
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The addition of long-circulating liposomes produced by either sonication (S3) or
extrusion (S4) also influenced SLO-induced hemolysis and diminished it in a concentrationdependent manner (Figure 6) similar to the regular liposomes. Hemolysis decayed steeply
with the amount of added liposomes and the EA50 values (5.0 ± 0.6 µg lipids for sonicated
liposomes and 6.8 ± 0.9 µg lipids for extruded liposomes) were similar to those determined
for regular liposomes as opposed to those observed for lysenin. The Hill coefficients
(p = 1.8 ± 0.1 for sonicated liposomes and p = 1.9 ± 0.2 for extruded liposomes) were also
similar to those determined for regular liposomes and were indicative of a slight positive
cooperativity and near complete inhibition of hemolysis for amounts exceeding 60 µg of
lipids. These results suggested that regular and long-circulating liposomes had a similar
efficacy in preventing the lytic activity of SLO irrespective of the production method.
Lysenin and SLO are similar with regard to presenting strong lytic activities that
may be diminished by either regular or long-circulating liposome addition. However, a
quantitative comparison of the two toxins indicated a few notable differences. For both
production methods, the amount of liposomes needed to prevent hemolysis were several
times larger for lysenin. The effective prevention of lysenin’s lytic activity (i.e., almost
complete abrogation of hemolysis) occurred at lipid amounts exceeding ~10 times the
amounts required to prevent SLO-induced lysis. As we adjusted the SLO and lysenin
amounts added to the reaction tubes such that they presented similar lytic activities (i.e.,
85% of full hemolysis elicited by a strong hypo-osmotic shock), these differences suggested
that either lysenin might present a greater lytic activity (which was expected because
different mechanisms of interaction with the target membranes were in effect) or that the
particular membrane composition utilized for this experiment presented a lower inhibition
efficacy. For example, lysenin has been reported to preferentially oligomerize into lipid
rafts [55–57]; therefore, only a reduced surface area of the liposome is available for binding
and pore formation. In contrast, if we assumed that the cholesterol was more uniformly
distributed into the membrane of the liposomes produced to prevent SLO-induced lysis, a
larger surface area would be available for interaction and the liposomes might remove the
SLO toxin in a more effective manner.
3.6. Cholesterol-Free Liposomes Do Not Prevent SLO-Induced Hemolysis
SLO belongs to the larger class of cholesterol-dependent cytolysins; therefore, binding,
oligomerization and pore formation are influenced by the presence of cholesterol in the
target membranes [58,59]. To assess how the presence of cholesterol in the membranes
of liposomes influenced SLO-induced hemolysis, we used Aso liposomes prepared by
sonication with and without the addition of Chol to the lipid mixture. The hemolysis
experiments were performed by using 1 mg total lipids/RBC sample. SLO alone induced
a strong hemolysis of RBCs (Figure 7). However, the addition of an equal amount of
liposomes composed of Aso and Chol (sample R3) abolished hemolysis and indicated a
complete inhibition. In contrast, the addition of an equal amount of liposomes composed
exclusively of Aso (sample RC2) presented a negligible inhibition of hemolysis, confirming
that cholesterol was required in the target membrane for strong binding.
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that PEGylation and lipid compositions may significantly influence PFT inhibition. Consesituations.
Our results showed that PEGylation and lipid compositions may significantly
quently, the adjustment of compositions and concentrations of liposomes may be needed
for optimal anti-PFT activity. However, this fact might be partially compensated by the
extended availability in the circulation of PEGylated liposomes and also be mitigated by the
ability to tailor liposome compositions to specific PFT families (i.e., cholesterol-dependent
cytolysins). Finally, as PEGylation and liposome composition may elicit immunological
responses that are dependent on the host, load and concentration [63,64], these aspects
should be considered for further in vivo investigations on PEGylated liposomes used for
PFT clearance.
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